Despite the economic impact of COVID-19 in 2020, this has been a record year for IPOin greater Boston, an incubator of tech and life science companies. Nineteen filed for IPOs and proceeded to go public in the first eight months of the year. Companies in greater Boston, a hotbed of life science research and its epicenter worldwide, have continued to work toward solving our most pressing health challenges, including research into COVID-19. The area continues to produce successful companies as it also remains a leader in education and highly skilled talent.